Abstract Information
KEY DATES
Date |
Deadline |
---|---|
Thursday, October 8, 2020 | Abstract Submission Site Opens |
Friday, January 15, 2021 | Abstract Submission Site Closes |
Monday, February 15, 2021 | Late Breaking Submission Site Opens |
Monday, March 1, 2021 | Regular submission notifiations sent to submitters |
Monday, March 1, 2021 | Late Breaking Submission Site Closes |
Thursday, March 11, 2021 | Regular submission presenting author registration deadline |
Around Friday, March 26, 2021 |
Late Breaking notifications sent to submitters |
Friday, April 2, 2021 | Late Breaking presenting author registration deadline |
*These dates are subject to change.
SUBMISSION TYPES
Oral
The highest ranked abstracts will be selected for oral presentation. Authors of abstracts selected for oral presentation will be informed about the session and date of presentation, and presentation guidelines will be provided.
Poster
Poster presenters will be informed about the date of the poster session and will receive guidelines for preparation and presentation.
All accepted abstracts will be published in The Journal of Extracellular Vesicles and will be made available on the congress website at the time of the meeting.
GENERAL ABSTRACT GUIDELINES
General abstract guidelines
ISEV2021 ABSTRACT TOPICS
EV biomarkers: Biomarkers beyond nucleic acids and proteins: sugars, lipids, metabolites |
EV biomarkers: EV nucleic acid biomarkers |
EV biomarkers: EV protein biomarkers |
EV-based therapeutics: Basis and requirements for clinical application - regulation and standardization/best-practices (e.g., GRP, GCP, and GMP) |
EV-based therapeutics: EVs as delivery vehicles |
EV-based therapeutics: EVs as intrinsic medicines (regenerative medicine, etc.) |
EV-based therapeutics: Pre-clinical data on animals or clinical trials (not in vitro data) |
EVs of specific cells, organs, diseases, and organisms: EVs in autoimmunity and inflammatory disorders |
EVs of specific cells, organs, diseases, and organisms: EVs in blood and blood disorders (e.g., coagulation, blood diseases) |
EVs of specific cells, organs, diseases, and organisms: EVs in cancer immunology and immunotherapy |
EVs of specific cells, organs, diseases, and organisms: EVs in cancer metastasis and tumor angiogenesis |
EVs of specific cells, organs, diseases, and organisms: EVs in cancer pathogenesis |
EVs of specific cells, organs, diseases, and organisms: EVs in cardiovascular diseases and vascular disorders |
EVs of specific cells, organs, diseases, and organisms: EVs in the central and peripheral nervous systems |
EVs of specific cells, organs, diseases, and organisms: EVs in veterinary medicine: beyond laboratory animals |
EVs of specific cells, organs, diseases, and organisms: EVs of non-mammalian organisms |
EVs of specific cells, organs, diseases, and organisms: EVs in the Immune system |
EVs of specific cells, organs, diseases, and organisms: EVs in infectious diseases and vaccines |
EVs of specific cells, organs, diseases, and organisms: EVs in kidney, urinary tract, and related diseases |
EVs of specific cells, organs, diseases, and organisms: EVs in metabolism and metabolic disease (liver disease, obesity, diabetes, metabolic syndrome) |
EVs of specific cells, organs, diseases, and organisms: EVs in musculoskeletal system - bone, muscle, tendon |
EVs of specific cells, organs, diseases, and organisms: EVs in reproduction & pregnancy |
EVs of specific cells, organs, diseases, and organisms: EVs in stem cells (including cancer stem cells) |
Fundamental biology and function of EVs: Biodistribution and cellular/organ targeting of EVs |
Fundamental biology and function of EVs: Cell-EV interaction, uptake, and fusion |
Fundamental biology and function of EVs: EV biogenesis (from prokaryotes to eukaryotes), component loading, and release |
Fundamental biology and function of EVs: EV signaling between cells/organs of multicellular organisms (not inter-organism) |
Fundamental biology and function of EVs: EV signaling between species |
Fundamental biology and function of EVs: EVs in tissue injury & repair |
Fundamental biology and function of EVs: EVs, matrikines, and the extracellular matrix |
Technologies and Methods: Advances in characterization of EV-associated molecules: not omics |
Technologies and Methods: Advances in characterization of EV-associated molecules: omics |
Technologies and Methods: Advances in EV quantitation |
Technologies and Methods: Advances in EV separation and concentration |
Technologies and Methods: Engineering and loading EVs |
Technologies and Methods: Microfluidic and other devices |
Technologies and Methods: Scientific outreach and collaboration: EV cores, workshops, other educational activities |
Technologies and Methods: Single-EV analysis |
Technologies and Methods: Virus and Virus-like particles (Biology and Characterisation) |